Algae Health Sciences Announces It Now Has 239 FDA-Allowed Structure/Function Claims for AstaZine® Natural Astaxanthin

May 5th, 2016

Irvine, California, May 5, 2016 – Algae Health Sciences, Inc., a subsidiary of BGG, announced today that it now has 239 Structure/Function claims which have been allowed by the US FDA for its flagship product AstaZine® Natural Astaxanthin.  AstaZine® is the world’s first Astaxanthin extracted from Certified Organic Haematococcus pluvialis microalgae.  AstaZine® is produced in a 100% glass tube photobioreactor (PBR) closed system on the world’s second largest Natural Astaxanthin farm.  “We’ve been working for months to attain this landmark achievement which now makes us the leader in this critical marketing category,” said Bob Capelli, EVP of Global Marketing for Algae Health Sciences.  “We have some extremely compelling claims that are now allowed for AstaZine®.  This will enable brands to successfully market Astaxanthin with an incredible variety of health claims.  Individual brands can customize their message to consumers while educating about Astaxanthin’s extensive clinically validated health benefits.”

Chief Operating Officer Lixin Ding, PhD added, “Astaxanthin has been validated in approximately 500 different medical research studies to positively affect eye & brain health, improve skin appearance and quality, support joints & tendons, promote cardiovascular health, and provide various benefits for athletes & active people.  And now with 239 allowed claims for labels and marketing literature, brands will easily and legally be able to tell US consumers just how beneficial Astaxanthin really is.”

AlgaeHealth produces AstaZine® in a variety of forms including 5% powder; 5%, 10% and 20% oleoresin; 2% water soluble powder; 2.0% and 2.5% microencapsulated beadlets.

 

*** ***

About Algae Health Sciences, Inc.:

Algae Health Sciences, Inc., a subsidiary of BGG, focuses on the production and marketing of efficacious ingredients from natural algae sources. Algae Health Science’s flagship product, AstaZine® Natural Astaxanthin is extracted from the world’s first Certified Organic Haematococcus pluvialis microalgae.  With the second largest capacity to produce Natural Astaxanthin from microalgae, Algae Health Sciences plans to become the world’s largest Astaxanthin producer in 2017. The company has facilities in USA, Switzerland, Japan and China.

Further information:  www.algaehealthsciences.com

Further Information about Astaxanthin: https://www.youtube.com/watch?v=KB-zd81TRus

 About BGG Group:

Founded in 1995, BGG specializes in the development and manufacture of fruit and botanical extracts, microalgae, natural vitamins, natural sweeteners and flavor enhancers for use in the dietary supplement, food/beverage, cosmetics and pharmaceutical industries. BGG employs about 400, has 5 production sites, international branches in USA, Switzerland, Japan and China and manages sales in more than 20 countries. BGG is ISO9001, ISO22000 and GMP certified.

Further Information on BGG: www.bggworld.com

 Press Contact:

 

AlgaeHealth 
Bob CapelliExecutive Vice President Global Marketingbob@algaehealthsciences.com

808.345.7711 (USA)

 

BGG

BGG is a global leader in the manufacture and sourcing of clinically-supported ingredients for the dietary supplement, cosmetics, and food and beverage industries.

© 2017 Beijing Ginko Group